miR-26a抑制转化生长因子beta诱导的韧带成纤维细胞增殖

目的:研究miR-26a对转化生长因子-β(Transforming growth factor-β,TGF-β)诱导的韧带成纤维细胞增殖的影响。方法:原代分离大鼠肩周韧带成纤维细胞,通过免疫荧光鉴定细胞纯度,应用脂质体细胞转染miRNA模拟物的方式过表达miR-26a,定量PCR的方法检测miR-26a模拟物的过表达效率,CCK8法检测细胞增殖能力的变化,生物信息学预测的方法分析miR-26a可能的作用靶基因。结果:免疫荧光检测发现原代分离细胞中,Vimentin阳性细胞在90%以上;转染miR-26a模拟物后,细胞内miR-26a水平显著高于阴性对照组(P<0.05);TGF-β刺激明显促进韧带成纤维细胞生长(P<0.01),而miR-26a则对TGF-β诱导的韧带成纤维细胞增殖具有显著的抑制作用(P<0.01);生物信息学预测显示SMAD1/4、EIF4G2、PTEN和MARK1可能是miR-26a影响细胞增殖的作用靶基因。结论:miR-26a可抑制TGF-β诱导的韧带成纤维细胞增殖。     

miR-155通过促进炎症因子释放参与脓毒症肠道屏障功能障碍的发生发展

摘要 目的：探讨miR-155在脓毒症致肠道功能障碍中的表达及作用。方法：（1）临床实验：以2022年5月至2022年8月入住新疆医科大学第一附属医院重症医学科的脓毒症患者和同期健康体检者为研究对象,根据急性胃肠损伤分级（AGI）将脓毒症患者分为AGI组和非AGI组。根据28 d生存情况分为存活组和死亡组,采用实时荧光定量反转录-聚合酶链反应（qRT-PCR）法前瞻性观察各组外周血miR-155的变化。（2）体内实验：将20只雄性S/D大鼠按照随机数字表法分为假手术组（sham组）和盲肠结扎穿孔术组（CLP组）,采用qRT-PCR及Western blot法检测miR-155、肠道紧密连接蛋白（ZO-1、claudin-1）的表达,ELISA法检测大鼠肠道组织中IL-1β、IL-6、IL-18的表达水平。(3)体外实验：培养人结直肠腺癌细胞（Caco-2）,并分为正常对照组(完全培养基培养48 h)、脂多糖组（完全培养基培养24 h后加入10 μg/mL LPS处理24 h）。采用qRT-PCR检测miR-155的表达。在倒置荧光显微镜下观察细胞形态的变化。采用CCK-8检测细胞活力。采用免疫荧光观察Caco-2细胞中紧密连接蛋白ZO-1分布的变化。并行细胞旁通透性实验,观察两组细胞旁通透性的变化。结果：（1）脓毒症组和健康对照组相比,脓毒症患者外周血miR-155较健康对照组明显升高,差异具有统计学意义（P<0.05）。AGI组患者外周血miR-155表达较非AGI组明显升高,差异具有统计学意义(P<0.05)。脓毒症死亡患者外周血miR-155表达显著升高(P<0.05)。（2）应用CLP模型进行体内动物实验,CLP组大鼠肠道组织miR-155表达较假手术组（sham组）明显升高。CLP组大鼠肠道紧密连接蛋白（ZO-1、claudin-1）较sham组下降,差异具有统 计学意义(P<0.05)。ELISA结果提示,CLP大鼠肠道组织中IL-1β、IL-6、IL-18水平较sham组显著升高（P<0.05）,且肠道组织中miR-155水平与IL-1β、IL-6、IL-18呈正相关（r=0.542,r=0.906,r=868,P<0.05）。（3）与正常对照组相比,经LPS处理后细胞形态破坏、细胞间紧密连接破坏、细胞活力减弱、细胞旁通透性增加。结论：脓毒症发生时伴有肠道屏障功能障碍,miR-155在脓毒症肠道屏障功能障碍中表达升高,并可能通过促进炎症因子的释放参与脓毒症肠道屏障功能障碍的发生发展。miR-155异常表达对脓毒症患者早期肠道功能障碍诊断及预后的评估具有重要价值,可作为脓毒症早期肠道损伤诊断及预后情况的重要指标。     

miRNA-105在胃癌组织中的表达情况

目的:分析胃癌组织与癌旁正常胃黏膜组织中miRNA的差异表达情况。方法:收集胃癌组织和其相应癌旁正常胃黏膜组织共33对,经抽提、纯化RNA后,反转录合成荧光分子Hy3的cDNA探针,将其与miRCURYTMLNA Array(v.16.0)(Exiqon公司)芯片进行杂交,应用Axon GenePix 4000B芯片扫描仪来扫描miRNA芯片的荧光强度,GenePix Pro 6.0软件(Axon)把图像转化为数字信号,以差异大于2倍的为标准来确定胃癌黏膜组织中差异表达的miRNA。再用实时荧光定量PCR方法验证芯片结果中表达异常增高的miR-105在33例胃癌组织中的表达情况。结果:miRNA表达谱芯片结果显示:胃癌组织共中有51种miRNA表达异常,其中miR-105、miR-548n、miR-214*、miR-4309等31种miRNA表达上调,miR-31、miR-1275、miR-26b*、miR-744等20种miRNA表达下调;实时荧光定量PCR证实与癌旁正常胃黏膜组织相比,胃癌组织中miR-105表达显著上调(P0.01)。结论:miR-105在胃癌组织的表达明显高于正常胃黏膜组织,可能与胃癌的发生、发展相关。我们的研究为胃癌的发病机制和诊断治疗提供了一个新的研究方向。     

Multiplicative genetic effects in scrapie disease susceptibility

Despite experimental evidence that scrapie is an infectious disease of sheep, variations of the occurrence of the natural disease suggest an influence of host genetic factors. It has been established that the genetic polymorphism of the prion protein (PrP) gene is correlated to the incidence of scrapie and to the survival time: five polymorphisms have been described by variations at amino-acid codons 136, 154 and 171. In this paper we study the effect on scrapie susceptibility of the pairing of the five allelic variants known to exist: we show that scrapie susceptibility is given by the produce of the elementary allelic factors. This first well-documented evidence of a multiplicative property of genetic risk factors could give hints on the underlying mechanisms of prion-induced neurodegenerative diseases.     

miR-155-5p增强卵巢癌细胞UWB1.289对PARP抑制剂的敏感性

摘要 目的：探讨卵巢癌细胞UWB1.289中miR-155-5p对PARP抑制剂敏感性的影响及可能涉及的分子机制研究。方法：采用qRT-PCR技术检测miR-155-5p在有BRCA1/2突变和无BRCA1/2突变的卵巢癌组织及卵巢癌细胞中的表达情况。利用细胞转染、qRT-PCR以及Western Blot技术检测转染miR-155-5p模拟物和抑制剂的卵巢癌细胞UWB1.289中miR-155-5p的表达以及同源重组修复相关基因SIRT1、BRG1的表达。通过双荧光素酶报告基因实验验证miR-155-5p与SIRT1、BRG1之间的靶向性。运用CCK-8检测卵巢癌细胞UWB1.289中miR-155-5p对PARP抑制剂敏感性的影响。结果：与无BRCA1/2突变的卵巢癌组织及卵巢癌细胞相比,miR-155-5p在有BRCA1/2突变的卵巢癌组织及卵巢癌细胞中低表达。转染miR-155-5p模拟物可增加卵巢癌细胞UWB1.289中miR-155-5p的表达,同时降低同源重组修复相关基因SIRT1、BRG1的表达;转染miR-155-5p抑制剂可下调卵巢癌细胞UWB1.289中miR-155-5p的表达,同时增加SIRT1、BRG1的表达,进一步通过双荧光素酶报告基因实验证实miR-155-5p与SIRT1、BRG1存在特异性靶向结合序列。与对照组相比,干扰同源重组修复相关基因以及miR-155-5p过表达均可增强卵巢癌细胞UWB1.289对PARP抑制剂的敏感性。结论：miR-155-5p可能通过影响同源重组修复基因增强卵巢癌细胞UWB1.289对PARP抑制剂的敏感性。     

MicroRNA-129-5p inhibits 3T3-L1 preadipocyte proliferation by targeting G3BP1

MicroRNAs have been regarded to play a crucial role in the proliferation of different cell types including preadipocytes. In our study, we observed that miR-129-5p was down-regulated during 3T3-L1 preadipocyte proliferation, while the expression of G3BP1 showed a contrary tendency. 5-Ethynyl-2′-deoxyuridine (EdU) incorporation assay and flow cytometry showed that overexpression of miR-129-5p could bring about a reduction in S-phase cells and G2-phase arrest. Additional study indicated that miR-129-5p impaired cell cycle-related genes in 3T3-L1 preadipocytes. Importantly, it showed that miR-129-5p directly targeted the 3′UTR of G3BP1 and the expression of G3BP1 was inhibited by miR-129-5p mimic. Moreover, miR-129-5p mimic activated the p38 signaling pathway through up-regulating p38 and the phosphorylation level of p38. In a word, results in our study revealed that miR-129-5p suppressed preadipocyte proliferation via targeting G3BP1 and activating the p38 signaling pathway.     

The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling

MiR-139-5p down-regulation has frequently been implicated in colorectal carcinoma. However, there is little known about its biological function between inflammation and cancer in vivo. Here, a transgenic murine model of colorectal carcinoma was used to investigate pathogenetic role of miR-139-5p in colitis and colitis-associated tumorigenesis. We showed that miR-139-5p knockout mice were higher sensitive to DSS-induced colitis and enhanced formation of intestinal neoplasia was observed when mice were exposed to AOM/DSS treatment. MiR-139-5p knockout mice exhibited an increased expression of genes involved in Wnt pathway. Such genes are closely associated with cell proliferation and differentiation, promoting the β-catenin nuclear accumulation. Furthermore, biochemical studies in HCT-116 cells revealed that the over-expression of miR-139-5p inhibited the crosstalk between PI3K/AKT and Wnt pathway mediated by IGF-1R. Collectively, these findings indicate that miR-139-5p plays a crucial role in the development and progression of colitis-associated tumorigenesis and suggest that miR-139-5p may serve as a potential therapeutic target for the treatment of colitis-associated cancer in the future.     

肿瘤干细胞标记物CD133与miR-429在大肠癌组织中的表达及其相关性研究

目的：检测CD133不同亚群大肠癌细胞HT-29的miR-429表达情况,探讨miR-429及CD133的表达与肿瘤的发生发展之间的关系。方法：采用荧光活化细胞分选法（FACS）分选出CD133不同亚群细胞,实时荧光定量PCR分别检测两组细胞miR-429的表达,合成miR-429寡核苷酸和阴性对照miRNA并分别转染CD133＋和CD133＋两个亚群细胞。再将细胞种植于非肥胖糖尿病／严重联合免疫缺陷（NOD／SCID）小鼠体内构建移植瘤模型,不同时间测量肿瘤体积和重量,RT—PCR及蛋白质印迹检测CD133＋和CD133＋两组肿瘤CD133mRNA和蛋白质表达。结果：血清检出CD133＋细胞为67．9％,miR-429的表达量是CD133＋细胞的（1．83±0．91）倍（P〈0．05）,CD133＋比例与miR-429表达呈负相关（r=0．591,P〈0．05）;miR-429＋／CD133＋组的移植瘤体积及重量与对照组比较有统计学差异（P〈0．05）,且miR-429＋/CD133＋组成瘤时间较对照组晚约2周,但miR-429＋/CD133＋组的移植瘤CD133表达量低,与阴性对照组比较无明显差异（P〉0．05）。结论：miR-429可能作为CD133的负性调控因子,具有抑制肿瘤生长的作用,但miR-429与CD133在肿瘤发生、发展过程中的作用机制有待进一步研究阐明。